Skip to main navigation Skip to search Skip to main content

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

ODYSSEY OUTCOMES Investigators, Gunnar Hilmar Gislason (Member of author group)

95 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science